Intravitreal Ranibizumab Injections Safely, Effectively Treat Non-AMD CNV

Wednesday, January 5, 2011

Comments

Ocular surgery News

Intravitreal ranibizumab showed potential benefit and a high safety profile in the treatment of choroidal neovascularization resulting from causes other than age-related macular degeneration, a study found.

Full Story

Retina Products and Equipment »

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:
1. apocrine hydrocystoma
2. basal cell carcinoma
3. chronic dacryocystitis
4. sebaceous cell carcinoma
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Intravitreal Ranibizumab Injections Safely, Effectively Treat Non-AMD CNV

Comments

Related Categories

Retina Products and Equipment »

Quick Quiz

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us